Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.55 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.55 |
| ▸ | MEN1 | O00255 | 2/20 | 0.55 |
| ▸ | HPGD | P15428 | 2/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.55 |
| ▸ | MAPT | P10636 | 2/20 | 0.55 |
| ▸ | CNR2 | P34972 | 13/20 | 0.51 |
| ▸ | CNR1 | P21554 | 7/20 | 0.51 |
| ▸ | ALDH3A1 | P30838 | 1/20 | 0.50 |
| ▸ | ALDH1A3 | P47895 | 1/20 | 0.50 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.50 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.48 |
| ▸ | GFER | P55789 | 2/20 | 0.48 |
| ▸ | PSMD14 | O00487 | 1/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
| ▸ | RECQL | P46063 | 1/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11769284 | 0.89 | ALDH1A1 (0.45) | ALDH1A1L3MBTL1MEN1HPGDKMT2A | |
| SCHEMBL9727341 | 0.84 | EGFR (0.42) | ALDH1A1L3MBTL1MEN1HPGDKMT2A | |
| SCHEMBL6313828 | 0.83 | ALDH1A1 (0.58) | ALDH1A1L3MBTL1MEN1HPGDKMT2A | |
| SCHEMBL9727371 | 0.81 | EGFR (0.45) | ALDH1A1MEN1HPGDKMT2AMAPT | |
| SCHEMBL3229040 | 0.79 | ALDH1A1 (0.65) | ALDH1A1L3MBTL1MEN1HPGDKMT2A | |
| SCHEMBL4408477 | 0.79 | ALDH1A1 (0.60) | ALDH1A1L3MBTL1MEN1HPGDKMT2A | |
| SCHEMBL23363660 | 0.78 | ALDH1A1 (0.41) | ALDH1A1L3MBTL1MEN1HPGDKMT2A | |
| SCHEMBL3225090 | 0.78 | CNR2 (0.48) | ALDH1A1MEN1KMT2AMAPTCNR2 | |
| SCHEMBL1972710 | 0.77 | ALDH1A1 (0.67) | ALDH1A1L3MBTL1MEN1HPGDKMT2A | |
| SCHEMBL332675 | 0.77 | ALDH1A1 (0.67) | ALDH1A1L3MBTL1MEN1HPGDKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116199603-A | Method for synthesizing N, N-diethyl-4-aminobenzenesulfonic acid by adopting continuous flow | 沈阳化工研究院有限公司 | 2023-06-02 | — | — | CN | disclosed |
| US-8236985-B2 | Compounds and uses thereof | IMPERIAL INNOVATIONS LTD. (GB) | 2012-08-07 | — | — | US | disclosed |
| US-20100063144-A1 | COMPOUNDS AND USES THEREOF | IMPERIAL INNOVATIONS LTD (GB) | 2010-03-11 | — | — | US | disclosed |
| US-5164514-A | Antispasmodics | ROUSSEL UCLAF (FR) | 1992-11-17 | — | — | US | disclosed |
| US-5081130-A | Antispasmodic agents | ROUSSEL UCLAF (FR) | 1992-01-14 | — | — | US | disclosed |
| US-5041436-A | 1-arylsulphonyl-2-piperidinone derivatives, process and intermediates for the preparation thereof, their application as antispasmodics and compositions containing them | ROUSSEL UCLAF (FR) | 1991-08-20 | — | — | US | disclosed |
| US-5037822-A | Antispasmodic agent | ROUSSEL-UCLAF (FR) | 1991-08-06 | — | — | US | disclosed |
| US-4990531-A | Antispasmodic agents | ROUSSEL UCLAF (FR) | 1991-02-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100063144-A1 | COMPOUNDS AND USES THEREOF | HDAC1, HDAC11, HDAC2 | ALDH1A1 150/4885L3MBTL1 596/4885MEN1 1240/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.